Phase 3 Readout~month
Phase 3 Topline: A Randomised Phase III Open Label Study of Regorafenib + Nivolumab vs Standard Chemotherapy in Refra
- Drug
- regorafenib
- Indication
- Gastro-Oesophageal Cancer
Other upcoming events for UTHR
Phase 2 StartPhase 2 Start: NANT 2021-02: A Randomized Phase 2 Study of 131I-MIBG With Vorinostat VS. 131I-MIBG With Dinutuximab
Phase 3 ReadoutPhase 3 Topline: Opiate-sparing Post-operative Pain Control in Septorhinoplasty: A Prospective Randomized, Double Bli
Phase 2 StartPhase 2 Start: Phase 2 Study to Assess the Safety and Efficacy of Bomedemstat (IMG-7289) in Combination With Momelo
Phase 3 ReadoutPhase 3 Topline: A Phase 3 Open-label Extension (OLE) Study to Evaluate the Long-term Safety and Efficacy of Ralinepa
Phase 3 ReadoutPhase 3 Topline: Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic,
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.